SHARES Spotlight interview with Andrew Newland CEO of Angle Plc

(6:6)

SHARES Spotlight interview with Andrew Newland CEO of Angle Plc

(6:6)

Shares Spotlight - Andrew Newland, CEO of Angle PLC

(11:36)

Angle (AGL) – Andrew Newland, Chief Executive

(22:34)

ANGLE CEO, Andrew Newland, Interview - Ovarian Cancer

(7:15)

ANGLE PLC's Andrew Newland updates as blood donations restart to support its key studies

(9:36)

Interview with Andrew Newland on 15 December 2015 - ANGLE plc First sales

(6:27)

ANGLE CEO Andrew Newland outlines the merits of the company's Parsortix System

(38:30)

Andrew Newland, Chief Executive of ANGLE (AGL)

(27:17)

Secrets to Google SEO Success without Spending - The Junto w/ Scott Rattigan \u0026 Guest Andrew Newland

(48:22)

ANGLE PLC’s new approach to Cancer diagnostics with Parsortix - One2One Investor Forum

(32:20)

ANGLE PLC presents at the Proactive One2One Investor Conference - January 11th

(32:30)

ANGLE plc - How the Parsortix system works

(40)

ANGLE Parsortix Procedure

(6:31)

Why The Raiders Beating Jacksonville Isn't As Bad As You Think

(28:10)

Making CTCs Clinically Relevant: A Next Generation CTC Enrichment System

(26:57)

ANGLE's CEO explains the huge significance of its prostate cancer collaboration

(13:21)

ANGLE says second pharma services contract shows confidence in 'totally new approach'

(7:14)

10 Best Places to Visit in New Zealand

(12:5)

ANGLE PLC's Andrew Newland on 'very exciting' liquid biopsy breakthrough

(8:19)

ANGLE (AGL) - Andrew Newland, Chief Executive \u0026 Ian Griffiths, FD

(27:32)

CEO Andrew Newland talks about ANGLE's Parsortix system on The Stock Market Show

(14:12)

Andrew Newland CEO ANGLE AGL

(31:48)

ANGLE (AGL) - Andrew Newland, Chief Executive \u0026 Ian Griffiths, FD

(30:1econd)

Andrew Newland discussing the conditional acquisition of certain assets of Axela Inc.

(6:36)

ANGLE - Andrew Newland

(15:45)

ANGLE CEO Andrew Newland outlines the merits of the company's Parsortix System

(29:7)

ANGLE PLC's Andrew Newland on 'breakthrough in culturing CTCs'

(8:58)

Andrew Newland - Functional Medicine Marketing Introduction

(1:19)

Andrew Newland, Chief Executive of ANGLE (AGL.L) at SHARES Magazines Innovators and Investors Forum

(19:19)